HLN
Price
$9.88
Change
+$0.03 (+0.30%)
Updated
Jul 25 closing price
Capitalization
38.4B
5 days until earnings call
HLUBF
Price
$3.70
Change
+$0.04 (+1.09%)
Updated
Apr 14 closing price
Capitalization
4.85B
Interact to see
Advertisement

HLN vs HLUBF

Header iconHLN vs HLUBF Comparison
Open Charts HLN vs HLUBFBanner chart's image
Haleon
Price$9.88
Change+$0.03 (+0.30%)
Volume$9.88M
Capitalization38.4B
H. Lundbeck A/S
Price$3.70
Change+$0.04 (+1.09%)
Volume$810
Capitalization4.85B
HLN vs HLUBF Comparison Chart in %
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. HLUBF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a StrongBuy and HLUBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (HLN: $9.88 vs. HLUBF: $3.70)
Brand notoriety: HLN and HLUBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLN: 73% vs. HLUBF: 100%
Market capitalization -- HLN: $38.4B vs. HLUBF: $4.85B
HLN [@Pharmaceuticals: Other] is valued at $38.4B. HLUBF’s [@Pharmaceuticals: Other] market capitalization is $4.85B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 0 FA rating(s) are green whileHLUBF’s FA Score has 1 green FA rating(s).

  • HLN’s FA Score: 0 green, 5 red.
  • HLUBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLN and HLUBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish while HLUBF’s TA Score has 2 bullish TA indicator(s).

  • HLN’s TA Score: 5 bullish, 3 bearish.
  • HLUBF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, HLN is a better buy in the short-term than HLUBF.

Price Growth

HLN (@Pharmaceuticals: Other) experienced а +2.92% price change this week, while HLUBF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than HLUBF($4.85B). HLN has higher P/E ratio than HLUBF: HLN (29.23) vs HLUBF (11.95). HLN YTD gains are higher at: 4.749 vs. HLUBF (-16.479). HLUBF has higher annual earnings (EBITDA): 2.94B vs. HLN (2.35B). HLUBF has more cash in the bank: 2.88B vs. HLN (994M). HLUBF has less debt than HLN: HLUBF (5.22B) vs HLN (9.46B). HLUBF has higher revenues than HLN: HLUBF (18.9B) vs HLN (11.3B).
HLNHLUBFHLN / HLUBF
Capitalization38.4B4.85B792%
EBITDA2.35B2.94B80%
Gain YTD4.749-16.479-29%
P/E Ratio29.2311.95245%
Revenue11.3B18.9B60%
Total Cash994M2.88B34%
Total Debt9.46B5.22B181%
TECHNICAL ANALYSIS
Technical Analysis
HLNHLUBF
RSI
ODDS (%)
Bullish Trend 2 days ago
53%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
25%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
37%
Bullish Trend 2 days ago
31%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
49%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
40%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PHD9.800.04
+0.41%
Pioneer Floating Rate Fund
FMDE35.220.14
+0.40%
Fidelity Enhanced Mid Cap ETF
IBMN26.770.01
+0.04%
iShares iBonds Dec 2025 Term Muni Bd ETF
HAIL32.56-0.05
-0.14%
SPDR® S&P Kensho Smart Mobility ETF
HYBX30.64-0.07
-0.21%
TCW High Yield Bond ETF

HLUBF and

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
18%
Poorly correlated
-3.38%
HLNCF - HLUBF
7%
Poorly correlated
-0.51%
ESAIY - HLUBF
5%
Poorly correlated
-0.28%
AKAN - HLUBF
2%
Poorly correlated
+0.79%
HLN - HLUBF
1%
Poorly correlated
+0.30%
More